Ed Zhang
Co-Founder & Chief Executive Officer Overland Pharmaceuticals
Seminars
Thursday 17th September 2026
Roundtable Discussion: Navigating Regulatory Expectations for Next-Generation Cell Therapies to Accelerate Translation to the Clinic
2:45 pm
- Discussing evolving regulatory requirements for CAR-T, TCR, cell therapies to align with compliance standards
- Exploring how regulators are adapting to next-generation modalities, including in vivo delivery and manufacturing innovations
- Identifying strategies to design development programs that meet regulatory expectations while accelerating clinical translation
Thursday 17th September 2026
Highlighting Overland Therapeutics’ GPRC5D/BCMA Dual CAR-T Clinical Data
5:00 pm
- Demonstrating early-stage clinical safety and efficacy performance to advance dual targeted cell therapies
- Discussing next steps for dual CAR-T innovation for complex diseases
